Pradeep Banerjee

3.7k total citations
85 papers, 3.1k citations indexed

About

Pradeep Banerjee is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Pradeep Banerjee has authored 85 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Cellular and Molecular Neuroscience, 22 papers in Molecular Biology and 19 papers in Psychiatry and Mental health. Recurrent topics in Pradeep Banerjee's work include Neuroscience and Neuropharmacology Research (34 papers), Advanced Statistical Process Monitoring (10 papers) and Alzheimer's disease research and treatments (10 papers). Pradeep Banerjee is often cited by papers focused on Neuroscience and Neuropharmacology Research (34 papers), Advanced Statistical Process Monitoring (10 papers) and Alzheimer's disease research and treatments (10 papers). Pradeep Banerjee collaborates with scholars based in United States, Canada and India. Pradeep Banerjee's co-authors include O. Carter Snead, Heikki Tanila, M. A. Rahim, Rimante Minkeviciene, A.H.M.A. Rahim, Richard W. Olsen, F.J. Arcelus, Robert Mihalek, Igor Spigelman and Zhiwei Li and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Neuroscience and Neurology.

In The Last Decade

Pradeep Banerjee

83 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pradeep Banerjee United States 29 1.5k 787 706 451 437 85 3.1k
Axel Becker Germany 35 2.3k 1.5× 1.3k 1.7× 466 0.7× 680 1.5× 413 0.9× 151 4.4k
Simon T. Bate United Kingdom 22 651 0.4× 528 0.7× 411 0.6× 228 0.5× 170 0.4× 51 1.6k
Will Spooren Switzerland 41 3.8k 2.6× 2.7k 3.4× 870 1.2× 1.8k 4.0× 217 0.5× 95 7.1k
Guiquan Chen China 28 792 0.5× 1.2k 1.5× 926 1.3× 237 0.5× 350 0.8× 95 3.1k
Diane Stephenson United States 34 843 0.6× 1.9k 2.5× 1.0k 1.5× 296 0.7× 622 1.4× 115 4.2k
David B. Keator United States 27 226 0.2× 522 0.7× 386 0.5× 910 2.0× 140 0.3× 89 2.5k
Andrew J. Shepherd United States 25 489 0.3× 555 0.7× 842 1.2× 74 0.2× 160 0.4× 69 2.2k
Judith A. Siuciak United States 31 2.5k 1.7× 1.8k 2.3× 1.1k 1.6× 821 1.8× 858 2.0× 53 5.4k
Jay Simon United States 31 2.3k 1.5× 1.6k 2.0× 404 0.6× 512 1.1× 495 1.1× 104 3.6k
Werner Schmidt Germany 46 4.5k 3.0× 2.2k 2.8× 627 0.9× 1.2k 2.7× 430 1.0× 212 7.1k

Countries citing papers authored by Pradeep Banerjee

Since Specialization
Citations

This map shows the geographic impact of Pradeep Banerjee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pradeep Banerjee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pradeep Banerjee more than expected).

Fields of papers citing papers by Pradeep Banerjee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pradeep Banerjee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pradeep Banerjee. The network helps show where Pradeep Banerjee may publish in the future.

Co-authorship network of co-authors of Pradeep Banerjee

This figure shows the co-authorship network connecting the top 25 collaborators of Pradeep Banerjee. A scholar is included among the top collaborators of Pradeep Banerjee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pradeep Banerjee. Pradeep Banerjee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Donello, John E., et al.. (2024). The NMDA receptor modulator zelquistinel durably relieves behavioral deficits in three mouse models of autism spectrum disorder. Neuropharmacology. 248. 109889–109889. 4 indexed citations
2.
Rajagopal, Lakshmi, et al.. (2022). Repeated administration of rapastinel produces exceptionally prolonged rescue of memory deficits in phencyclidine-treated mice. Behavioural Brain Research. 432. 113964–113964. 4 indexed citations
3.
Navratilova, Edita, Sasan Behravesh, Janice Oyarzo, et al.. (2020). Ubrogepant does not induce latent sensitization in a preclinical model of medication overuse headache. Cephalalgia. 40(9). 892–902. 57 indexed citations
4.
Navratilova, Edita, Janice Oyarzo, David W. Dodick, Pradeep Banerjee, & Frank Porreca. (2020). Efficacy of Ubrogepant in a Preclinical Model of Medication Overuse Headache (1148). Neurology. 94(15_supplement). 1 indexed citations
5.
Moore, Eric L., Mark E. Fraley, Ian M. Bell, et al.. (2020). Characterization of Ubrogepant: A Potent and Selective Antagonist of the Human Calcitonin Gene‒Related Peptide Receptor. Journal of Pharmacology and Experimental Therapeutics. 373(1). 160–166. 51 indexed citations
6.
Pothula, Santosh, Rong-Jian Liu, Min Wu, et al.. (2020). Positive modulation of NMDA receptors by AGN-241751 exerts rapid antidepressant-like effects via excitatory neurons. Neuropsychopharmacology. 46(4). 799–808. 27 indexed citations
7.
Pothula, Santosh, T. KATO, Rong-Jian Liu, et al.. (2020). Cell-type specific modulation of NMDA receptors triggers antidepressant actions. Molecular Psychiatry. 26(9). 5097–5111. 69 indexed citations
8.
Moore, Eric L., Christopher S. Burgey, Mark E. Fraley, et al.. (2019). Characterization of Ubrogepant: A Potent and Selective Antagonist of the Human Calcitonin Gene-Related Peptide Receptor (P4.10-021). Neurology. 92(15_supplement). 2 indexed citations
9.
Sahli, Zeyad T., Pradeep Banerjee, & Frank I. Tarazi. (2016). The Preclinical and Clinical Effects of Vilazodone for the Treatment of Major Depressive Disorder. Expert Opinion on Drug Discovery. 11(5). 515–523. 56 indexed citations
10.
Oosting, Ronald S., Johnny S.W. Chan, Berend Olivier, et al.. (2016). Differential effects of vilazodone versus citalopram and paroxetine on sexual behaviors and serotonin transporter and receptors in male rats. Psychopharmacology. 233(6). 1025–1034. 14 indexed citations
11.
Gao, Yonglin, Ralphiel S. Payne, Avital Schurr, et al.. (2011). Memantine reduces mania-like symptoms in animal models. Psychiatry Research. 188(3). 366–371. 29 indexed citations
12.
Ray, Balmiki, Pradeep Banerjee, Nigel H. Greig, & Debomoy K. Lahiri. (2009). Memantine treatment decreases levels of secreted Alzheimer's amyloid precursor protein (APP) and amyloid beta (Aβ) peptide in the human neuroblastoma cells. Neuroscience Letters. 470(1). 1–5. 41 indexed citations
13.
Bailey, Jason A., Balmiki Ray, Lakshman Puli, et al.. (2009). Memantine lowers amyloid‐β peptide levels in neuronal cultures and in APP/PS1 transgenic mice. Journal of Neuroscience Research. 88(1). 143–154. 110 indexed citations
14.
Martínez‐Coria, Hilda, Kim N. Green, Lauren M. Billings, et al.. (2009). Memantine Improves Cognition and Reduces Alzheimer’s-Like Neuropathology in Transgenic Mice. American Journal Of Pathology. 176(2). 870–880. 174 indexed citations
15.
Scholtzova, Henrieta, Youssef Zaim Wadghiri, Einar M. Sigurdsson, et al.. (2008). Memantine leads to behavioral improvement and amyloid reduction in Alzheimer's‐disease‐model transgenic mice shown as by micromagnetic resonance imaging. Journal of Neuroscience Research. 86(12). 2784–2791. 104 indexed citations
16.
Minkeviciene, Rimante, Jouni Ihalainen, Tarja Malm, et al.. (2007). Age‐related decrease in stimulated glutamate release and vesicular glutamate transporters in APP/PS1 transgenic and wild‐type mice. Journal of Neurochemistry. 105(3). 584–594. 176 indexed citations
17.
Nyakas, Csaba, Robert M. Szabo, Botond Penke, Pradeep Banerjee, & Paul G.M. Luiten. (2006). Memantine Rescues Cholinergic Neurons from the Neurotoxic Effects of β-Amyloid (Aβ1-42). European Neuropsychopharmacology. 16(3). 1 indexed citations
18.
Banerjee, Pradeep, et al.. (2000). Regulation of γ-aminobutyric acid (GABA) release in cerebral cortex in the γ-hydroxybutyric acid (GHB) model of absence seizures in rat. Neuropharmacology. 39(3). 427–439. 51 indexed citations
19.
Banerjee, Pradeep, et al.. (1996). Inspection Policies for Repairable Systems. IIE Transactions. 28(12). 1003–1010. 10 indexed citations
20.
Banerjee, Pradeep & M. A. Rahim. (1988). Economic Design of – Control Charts Under Weibull Shock Models. Technometrics. 30(4). 407–414. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Axel Becker Breakdown of academic impact, for papers by Simon T. Bate Breakdown of academic impact, for papers by Will Spooren Breakdown of academic impact, for papers by Guiquan Chen Breakdown of academic impact, for papers by Diane Stephenson Breakdown of academic impact, for papers by David B. Keator Breakdown of academic impact, for papers by Andrew J. Shepherd Breakdown of academic impact, for papers by Judith A. Siuciak Breakdown of academic impact, for papers by Jay Simon Breakdown of academic impact, for papers by Werner Schmidt
Rankless by CCL
2026